Years of life lost as a measure of cancer burden on a national level

Por Brustugun, O T, Møller, B, Helland, Å
Publicado em 2014

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

Por Skomedal, H., Kristensen, G., Helland, A., Nesland, J. M., Kooi, S., Børresen, A. L., Holm, R.
Publicado em 1995

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Por Helland, A., Karlsen, F., Due, E. U., Holm, R., Kristensen, G., Børresen-Dale, A. l.
Publicado em 1998

TP53 mutations among molecular subtypes of HER2-positive tumors

Por Helland, Å, Nicolau, M, Ji, Y, Langerød, A, Sommervoll, DE, Bergamaschi, A, Pollack, JR, Børresen-Dale, A-L, Jeffrey, SS
Publicado no Breast Cancer Res (2005)

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival

Por Wang, Y, Helland, Å, Holm, R, Skomedal, H, Abeler, V M, Danielsen, H E, Tropé, C G, Børresen-Dale, A-L, Kristensen, G B
Publicado em 2004

Clinical significance of disseminated tumour cells in non-small cell lung cancer

Por Rud, A K, Borgen, E, Mælandsmo, G M, Flatmark, K, Le, H, Josefsen, D, Solvoll, I, Schirmer, C B, Helland, Å, Jørgensen, L, Brustugun, O T, Fodstad, Ø, Boye, K
Publicado em 2013

High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival

Por Helland, Å., Brustugun, O. T., Nakken, S., Halvorsen, A. R., Dønnem, T., Bremnes, R., Busund, L. T., Sun, J., Lorenz, S., Solberg, S. K., Jørgensen, L. H., Vodak, D., Myklebost, O., Hovig, E., Meza‐Zepeda, L. A.
Publicado no Int J Cancer (2017)